These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2860687)

  • 1. Pilot investigation of the quantitative EEG and clinical effects of ketazolam and the novel antiemetic nonabine in normal subjects.
    McClelland GR; Sutton JA
    Psychopharmacology (Berl); 1985; 85(3):306-8. PubMed ID: 2860687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further assessment of benzodiazepine-tricyclic antidepressant interaction. Effectiveness of combined treatment with ketazolam-nortriptyline on conflict behaviour in rats.
    Cannizzaro G; Brucato AF; Provenzano PM
    Arzneimittelforschung; 1982; 32(9):1111-3. PubMed ID: 6128985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory and sedative effects of clobazam and clonazepam in volunteers.
    Wildin JD; Pleuvry BJ; Mawer GE; Onon T; Millington L
    Br J Clin Pharmacol; 1990 Feb; 29(2):169-77. PubMed ID: 2106335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364.
    Saletu B; Grünberger J; Cepko H
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):421-37. PubMed ID: 2888736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiemetic effect of nonabine in cancer chemotherapy: a double blind study comparing nonabine and chlorpromazine.
    Archer CB; Amlot PL; Trounce JR
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):350-1. PubMed ID: 6402096
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of extremely low doses of phenazepam on EEG of rats and their behavior in various models of anxiety].
    Voronina TA; Molodavkin GM; Cherniavskaia LI; Seredenin SB; Burlakova EB
    Biull Eksp Biol Med; 1997 Sep; 124(9):308-10. PubMed ID: 9445614
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correlation of the clinical pharmacological action of a single dose of fenazepam with the EEG dynamics and pharmacokinetics].
    Uvarova LG; Zherdev VP; Neznamov GG; Khrulenko-Varnitskiĭ IO; Sigunova EA
    Farmakol Toksikol; 1986; 49(1):66-9. PubMed ID: 2868919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the therapeutic effect, tolerance and safety of ketazolam and diazepam administered for six months to out-patients with chronic anxiety neurosis.
    Fabre LF; McLendon DM; Stephens AG
    J Int Med Res; 1981; 9(3):191-8. PubMed ID: 6113174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic efficacy and safety of ketazolam compared with diazepam and placebo.
    Kim KK; Sirman A; Trainor FS; Lee BY
    Clin Ther; 1980; 3(1):9-14. PubMed ID: 6105920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and EEG effects of benzodiazepines and their antagonists in the cat.
    Ongini E
    Adv Biochem Psychopharmacol; 1983; 38():211-25. PubMed ID: 6142604
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated RO 15-1788 administration in benzodiazepine-dependent baboons.
    Lamb RJ; Griffiths RR
    Eur J Pharmacol; 1985 Apr; 110(2):257-61. PubMed ID: 2859217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of anxiety with ketazolam in elderly patients.
    Bresolin N; Monza G; Scarpini E; Scarlato G; Straneo G; Martinazzoli A; Benincà G; Cattoni C; De Candia R; Belloni G
    Clin Ther; 1988; 10(5):536-42. PubMed ID: 2908803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketazolam compared to diazepam and placebo in the treatment of anxiety.
    Kleber RJ
    J Int Med Res; 1980; 8(6):439-45. PubMed ID: 6108266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ethyl loflazepate (CM 6912) on sleep in normal humans.
    Mizuki Y; Kuwahara H; Isozaki H; Tanaka M; Inanaga K
    Methods Find Exp Clin Pharmacol; 1988 Jun; 10(6):401-6. PubMed ID: 2900918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the benzodiazepine antagonist Ro 15-1788 after "general anaesthetic" doses of benzodiazepines in mice.
    Little HJ; Bichard AR
    Br J Anaesth; 1984 Oct; 56(10):1153-60. PubMed ID: 6148095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketazolam treatment for spasticity: double-blind study of a new drug.
    Basmajian JV; Shankardass K; Russell D; Yucel V
    Arch Phys Med Rehabil; 1984 Nov; 65(11):698-701. PubMed ID: 6149738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.
    Higgitt A; Lader M; Fonagy P
    Psychopharmacology (Berl); 1986; 89(4):395-403. PubMed ID: 3092269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.